ScreenerHero

BBMBlueberries Medical Corp.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · blueberriesmed.com
0.0150CAD0.00%Mkt Cap: 5.41M $P/E: —

Blueberries Medical Corp., a consumer science company, engages in the commercialization of medicinal cannabis and related products in Colombia. The company produces and distributes psychoactive and non-psychoactive canna…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$62.66BUSDP/E 24.3
TAK
Takeda Pharmaceutical Company Limited
$60.33BUSD
TEVA
Teva Pharmaceutical Industries Limited
$46.72BUSDP/E 66.8
HLN
Haleon plc
$41.16BUSDP/E 19.5
ZTS
Zoetis Inc.
$29.48BUSDP/E 11.6
ZOE
Zoetis Inc.
$27.77BUSDP/E 11.6
UTHR
United Therapeutics Corporation
$21.22BUSDP/E 17.7
VTRS
Viatris, Inc.
$19.47BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.80BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.63BUSDP/E 21.0
IPN
Ipsen S.A.
$13.27BUSDP/E 24.0
ELAN
Elanco Animal Health Incorporated
$11.20BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.33BUSDP/E 30.2
KRK
Krka, d. d.
$8.66BUSDP/E 18.8
ALKS
Alkermes plc
$7.41BUSDP/E 116.3
AMRX
Amneal Pharmaceuticals, Inc.
$7.02BUSDP/E 42.0
HIMS
Hims & Hers Health, Inc.
$6.85BUSD
LNTH
Lantheus Holdings, Inc.
$6.55BUSDP/E 24.0
KNSA
Kiniksa Pharmaceuticals International, plc
$6.10BUSDP/E 78.9
LQDA
Liquidia Corporation
$5.95BUSDP/E 47.5

Key Statistics

Company
Market Cap5.41M $
Enterprise Value5.69M $
Revenue (TTM)202.61K $
Gross Profit107.65K $
Net Income (TTM)-1.21M $
Revenue/Share0.0007 USD
Last Price0.0150 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA09609Y1016
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-11.07
EV/Revenue28.09
P/S26.69
P/B—
EPS (TTM)0.00
EPS (Forward)—
52W Range
0.010050% of range0.0200
52W High0.0200 CAD
52W Low0.0100 CAD
Profitability
Gross Margin47.34%
Oper. Margin-497.54%
EBITDA Margin-253.69%
Profit Margin-533.44%
ROE-518.68%
ROA-245.12%
Growth
Revenue Growth-37.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-905.30K $
CapEx (TTM)—
FCF Margin7.86%
FCF Yield0.29%
Net Debt283.42K $
Net Debt/EBITDA-0.55
Balance Sheet
Debt/Equity0.43
Current Ratio0.44
Quick Ratio0.32
Book Value/Sh0.0000 CAD
Cash/Share0.0000 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJul 4, 2018
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.495.09M
Float128.50M
Insiders74.04%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short97
Short (prev mo.)519
Technical
SMA 500.0148 (+1.4%)
SMA 2000.0139 (+8.1%)
Beta2.56
S&P 52W Chg14.29%
Avg Vol (30d)41.44K
Avg Vol (10d)16.70K
Technical Indicators
RSI (14)53.2
MACD0.0005
MACD Signal0.0007
MACD Hist.-0.0002
BB Upper0.0192 CAD
BB Middle0.0152 CAD
BB Lower0.0113 CAD
BB Width51.68%
ATR (14)0.0009 CAD
Vol Ratio (20d)3.42x